RS41904A - Makrolidi - Google Patents

Makrolidi

Info

Publication number
RS41904A
RS41904A YU41904A YUP41904A RS41904A RS 41904 A RS41904 A RS 41904A YU 41904 A YU41904 A YU 41904A YU P41904 A YUP41904 A YU P41904A RS 41904 A RS41904 A RS 41904A
Authority
RS
Serbia
Prior art keywords
amino
oxo
dihydro
cyclopropyl
ethyl
Prior art date
Application number
YU41904A
Other languages
English (en)
Serbian (sr)
Inventor
Sulejman Alihodžić
Daniele Andreotti
Andrea Berdik
Ilaria Bientinesi
Stefano Biondi
Manuela Ciraco
Federica Damiani
Marko Djerek
Miljenko Dumić
Vesna Eraković
Antun Hutinec
Gorjan Lazarevski
Sergio Lociuro
Nataša Marsić
Zorica Marušić-Istuk
Stjepan Mutak
Alfredo Paio
Dražen Pavlović
Anna Quaglia
Wolfgang Schoenfeld
Vlado Štimac
Jessica Tibasco
Original Assignee
Glaxo Group Limited
Pliva D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited, Pliva D.D. filed Critical Glaxo Group Limited
Publication of RS41904A publication Critical patent/RS41904A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
YU41904A 2001-11-14 2002-11-13 Makrolidi RS41904A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides

Publications (1)

Publication Number Publication Date
RS41904A true RS41904A (sr) 2006-10-27

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
YU41904A RS41904A (sr) 2001-11-14 2002-11-13 Makrolidi

Country Status (20)

Country Link
US (1) US7202221B2 (enExample)
EP (1) EP1453846B1 (enExample)
JP (1) JP2005515978A (enExample)
CN (1) CN1307194C (enExample)
AR (1) AR037371A1 (enExample)
AT (1) ATE362479T1 (enExample)
BR (1) BR0214132A (enExample)
CA (1) CA2466975A1 (enExample)
DE (1) DE60220180T2 (enExample)
EA (1) EA007433B1 (enExample)
ES (1) ES2287332T3 (enExample)
GB (1) GB0127349D0 (enExample)
HR (1) HRP20040433A2 (enExample)
HU (1) HUP0402225A3 (enExample)
IL (1) IL161710A0 (enExample)
PL (1) PL371472A1 (enExample)
RS (1) RS41904A (enExample)
UA (1) UA77210C2 (enExample)
WO (1) WO2003042228A1 (enExample)
ZA (1) ZA200403684B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
EP1503759B1 (en) * 2002-05-14 2008-12-17 The Regents Of The University Of California Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
HRP20070094T3 (hr) * 2003-05-13 2008-05-31 Glaxo Group Limited NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
ES2331739T3 (es) * 2004-05-06 2010-01-14 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolidos que contienen enlaces ester utiles para el tratamiento de infecciones microbianas.
WO2005108413A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Carbamate linked macrolides useful for the treatment of microbial infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2008017696A1 (en) 2006-08-09 2008-02-14 Basilea Pharmaceutica Ag New macrolides useful against inflammatory and allergic disseases
EP2056844A4 (en) 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
WO2009106419A1 (en) 2008-02-08 2009-09-03 Basilea Pharmaceutica Ag New macrolides and their use
BRPI1011959A2 (pt) 2009-05-27 2016-04-26 Wockhardt Research Center compostos de cetolídeo tendo atividade antimicrobiana.
KR101657751B1 (ko) 2010-12-09 2016-09-19 욱크하르트 리미티드 케토라이드 화합물
CA2826174A1 (en) * 2011-01-31 2012-08-09 Meiji Seika Pharma Co., Ltd. Novel macrolide derivative
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates
CN119060110A (zh) * 2023-05-30 2024-12-03 北京理工大学 一种红霉素衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
US4742049A (en) 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
CA2049359A1 (en) * 1989-03-28 1990-09-29 Leslie A. Freiberg Erythromycin derivatives
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
BR9708929A (pt) 1996-05-07 1999-08-03 Abbott Lab Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
HK1045523A1 (zh) 1999-05-24 2002-11-29 辉瑞产品公司 13-甲基红霉素衍生物
BR0009101A (pt) 1999-08-24 2002-02-05 Abbott Lab 9a-azalidas com atividade antibacteriana
ATE312839T1 (de) 2000-02-24 2005-12-15 Abbott Lab Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
US6946446B2 (en) * 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
IL161710A0 (en) 2004-09-27
US7202221B2 (en) 2007-04-10
CN1307194C (zh) 2007-03-28
HRP20040433A2 (en) 2005-04-30
HUP0402225A2 (hu) 2005-02-28
WO2003042228A1 (en) 2003-05-22
UA77210C2 (en) 2006-11-15
US20050080025A1 (en) 2005-04-14
PL371472A1 (en) 2005-06-13
GB0127349D0 (en) 2002-01-02
HUP0402225A3 (en) 2006-01-30
DE60220180T2 (de) 2008-01-17
CN1612888A (zh) 2005-05-04
AR037371A1 (es) 2004-11-03
DE60220180D1 (de) 2007-06-28
ATE362479T1 (de) 2007-06-15
EP1453846A1 (en) 2004-09-08
ES2287332T3 (es) 2007-12-16
EP1453846B1 (en) 2007-05-16
EA007433B1 (ru) 2006-10-27
JP2005515978A (ja) 2005-06-02
ZA200403684B (en) 2005-09-13
EA200400536A1 (ru) 2004-12-30
CA2466975A1 (en) 2003-05-22
BR0214132A (pt) 2004-09-14

Similar Documents

Publication Publication Date Title
RS41904A (sr) Makrolidi
JP2004520314A (ja) マクロライド抗生物質
KR20070085919A (ko) 마크로론 - 아미노 치환된 퀴놀론
JP2007536371A (ja) 微生物感染症の治療に有用なエステル結合マクロライド
US7351696B2 (en) Compounds
EP0262904A2 (en) Modifications of mycinose and 3-0-demethylmycinose in tylosintype macrolides
JP2008519787A (ja) マクロロン化合物
EP1328535B1 (en) Macrolides
JP2006528947A (ja) ４”−置換マクロライド
JP2007502313A (ja) 新規１４及び１５員環化合物
WO2006120541A1 (en) Ether linked macrolides useful for the treatment of microbial infections
WO2004101589A1 (en) Novel 14 and 15 membered-ring compounds
EP0262903A2 (en) New acyl derivatives of 20-modified tylosin and desmycosin compounds
WO2006120545A1 (en) 4' amino linked macrolides useful for the treatment of microbial infections
JP2007536372A (ja) 微生物感染症の治療に有用なカルバミン酸エステル結合マクロライド
JP2006528668A (ja) 新規１４−及び１５−員環マクロライド
KR20070031900A (ko) 미생물 감염의 치료에 유용한 에스테르 연결된마크롤라이드